Mozart Effect Myth: There is no research showing that Mozart's music has any effect on epilepsy

Published Date: 08 Mar 2023

Over the past 50 years, there has been much speculation about the quality of Wolfgang Amadeus Mozart's music. The report indicates that listening to Mozart's sonata KV448 in epilepsy patients reduces symptoms is interesting...

Read Full News

Latest News

What is Causing This MS Patient's Unusual Symptoms?

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

This Unusual Syndrome of the Face Could Be an Early Sign of AML

Case started with severe pain and numbness

New Autism Committee Chair Founded a Leucovorin Telehealth Company

Drug has been promoted as a treatment for autism

Possible Drug-Drug Interactions Flagged for Older Americans

— Many are on 5+ prescription drugs or dietary supplements

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

Todays Updates

ASTRO: American Society for Radiation Oncology

Todays Updates

ASTRO: American Society for Radiation Oncology

Latest News

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

Case started with severe pain and numbness

Drug has been promoted as a treatment for autism

— Many are on 5+ prescription drugs or dietary supplements

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

News All Time

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Federal Committee Looks Backward as Autism Science Moves Forward

In its second meeting, federal autism committee advances plan that may stymie promising research

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

Guidelines from AAN and AHS get first update since 2012

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis, BMS reportedly halt trials; first serious blow to burgeoning field

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Recommended News For You

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

Researchers discover that children who survive cancer have socioeconomic challenges.

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

Study finds primary-care doctors often overlook prostate cancer risk in Black men

AVD Chemo Regimen Shows Promise in Older Patients With HL

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

Recommended Articles For You

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress 

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How artificial intelligence could significantly improve the prognosis for cancer patients.

2.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

3.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

4.

How a California Oncologist Making $850k Spends Money

5.

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts

1.

What You Need to Know About the Early Warning Signs of Colon Cancer 

2.

Ferroptosis-Modulating Therapeutics in Precision Oncology

3.

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes

4.

Uncovering the Mysteries of the RDW Blood Test

5.

Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Understanding the Importance of Follow-Up After Cancer Treatment

4.

Efficient Management of First line ALK-rearranged NSCLC

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot